Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity
Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.
Highlighted with 79 tables and 70 figures, this 144-page report “Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Region.
Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Types
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Oncology Diagnosis
• Hepatitis Diagnosis
• Infectious Disease Diagnosis
• Dengue Diagnostics
• Tuberculosis Diagnostics
• HIV Diagnostics
• Other Applications
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hospitals & Clinics
• Diagnostic Laboratories
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34
3 Segmentation of Global Market by Type 38
3.1 Market Overview by Type 38
3.2 Monoclonal Antibodies 40
3.3 Polyclonal Antibodies 41
3.4 Other Types 42
4 Segmentation of Global Market by Application 43
4.1 Market Overview by Application 43
4.2 Oncology Diagnosis 45
4.3 Hepatitis Diagnosis 46
4.4 Infectious Disease Diagnosis 47
4.5 Dengue Diagnostics 48
4.6 Tuberculosis Diagnostics 49
4.7 HIV Diagnostics 50
4.8 Other Applications 51
5 Segmentation of Global Market by End User 52
5.1 Market Overview by End User 52
5.2 Hospitals & Clinics 54
5.3 Diagnostic Laboratories 55
5.4 Other End Users 56
6 Segmentation of Global Market by Region 57
6.1 Geographic Market Overview 2020-2027 57
6.2 North America Market 2020-2027 by Country 61
6.2.1 Overview of North America Market 61
6.2.2 U.S. 64
6.2.3 Canada 67
6.2.4 Mexico 69
6.3 European Market 2020-2027 by Country 71
6.3.1 Overview of European Market 71
6.3.2 UK 74
6.3.3 France 76
6.3.4 Germany 78
6.3.5 Spain 80
6.3.6 Italy 82
6.3.7 Russia 84
6.3.8 Rest of European Market 86
6.4 Asia-Pacific Market 2020-2027 by Country 88
6.4.1 Overview of Asia-Pacific Market 88
6.4.2 China 91
6.4.3 Japan 93
6.4.4 India 96
6.4.5 Australia 98
6.4.6 South Korea 100
6.4.7 Rest of APAC Region 102
6.5 South America Market 2020-2027 by Country 104
6.5.1 Argentina 107
6.5.2 Brazil 109
6.5.3 Chile 111
6.5.4 Rest of South America Market 113
6.6 MEA Market 2020-2027 by Country 114
6.6.1 UAE 117
6.6.2 Saudi Arabia 119
6.6.3 South Africa 121
6.6.4 Other National Markets 123
7 Competitive Landscape 124
7.1 Overview of Key Vendors 124
7.2 New Product Launch, Partnership, Investment, and M&A 127
7.3 Company Profiles 128
Abbott Laboratories 128
Abcam plc 130
Agilent Technologies, Inc. 131
Aytu BioScience, Inc. 132
Becton, Dickinson and Company 133
Bio-Rad Laboratories, Inc. 134
Boehringer Ingelheim International GmbH 135
Creative Diagnostics 136
Enzo Life Sciences, Inc. 137
F. Hoffmann-La Roche AG 138
Merck KGaA 139
Polymun Scientific Immunbiologische Forschung GmbH 140
Sanofi S.A. 141
Sartorius AG 142
Thermo Fisher Scientific Inc. 143
RELATED REPORTS 144
Research Methodology:
Diagnostic Specialty Antibodies Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|